Tang H, et al. - Researchers evaluated the correlation between voriconazole use and risk of squamous cell carcinoma (SCC). In individuals with lung transplant or hematopoietic cell transplant, an increased risk of SCC associated with voriconazole was supported in the findings. Especially among individuals at high risk of developing SCC, authors suggested performing routine dermatologic surveillance. Results did not demonstrate an association of voriconazole use with increased risk of basal cell carcinoma.